rs387907378
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP4
The NM_014585.6(SLC40A1):c.1112G>A(p.Arg371Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000496 in 1,614,052 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R371W) has been classified as Likely benign.
Frequency
Consequence
NM_014585.6 missense
Scores
Clinical Significance
Conservation
Publications
- hemochromatosis type 4Inheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152166Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000239 AC: 6AN: 251210 AF XY: 0.0000368 show subpopulations
GnomAD4 exome AF: 0.0000527 AC: 77AN: 1461886Hom.: 0 Cov.: 32 AF XY: 0.0000564 AC XY: 41AN XY: 727244 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152166Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74334 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:2Other:1
The R371Q variant in the SLC40A1 gene has been reported previously in an individual with hemochromatosis type 4 (Le Lan et al., 2011). The R371Q variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. Functional studies showed the R371Q variant protein did not provoke an export iron defect or hepcidin resistance, but showed a lower expression of the protein on the cell membrane (Détivaud et al., 2013). The R371Q variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is not conserved. We interpret R371Q as a variant of uncertain significance. -
- -
- -
Hemochromatosis type 4 Uncertain:1
This sequence change replaces arginine with glutamine at codon 371 of the SLC40A1 protein (p.Arg371Gln). The arginine residue is highly conserved and there is a small physicochemical difference between arginine and glutamine. This variant is present in population databases (rs387907378, ExAC 0.001%). This missense change has been observed in individual(s) with hyperferritinemia (PMID: 21199650). ClinVar contains an entry for this variant (Variation ID: 56154). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The glutamine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. Experimental studies have shown that this missense change does not substantially affect SLC40A1 function (PMID: 23943237). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at